INOH In Ovations Holdings Inc New (CE)

In Ovations Holdings, Inc. Has Appointed Mel Ehrlich, Ph.D. as a Director and Vice-President of Technology Effective April 28, 2014

DORAL, FL--(Marketwired - Apr 29, 2014) - In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) has appointed Mel Ehrlich, Ph.D. as a Director and Vice-President of Technology effective April 28, 2014.

Dr. Ehrlich is CEO of Nano Biomed, Inc., a company which has licensed patented nanoparticle technologies in which the nanoparticles deliver nitric oxide (NO). The Nano NO has been tested on animals for applications such as accelerated wound healing and sepsis. He is also CEO of Cytest Labs, Inc. Cytest Labs develops optical scanners using Ultra-Violet (UV) light and a pattern recognition computer to measure and analyze human body cell parameters. Cellular material is obtained from lung cells from deep early morning coughs. The system is designed for the early detection of lung cancer.

From 2003 to the present, he has served as Chairman and Chief Executive Officer of Efficient Energy Conversion Systems, Inc. (EECS). EECS has designed and patented significant improvements in oil burners and internal combustion (IC) engines. A US patent was awarded to Dr. Ehrlich in Aug. 2010 for his "Plasma Plug" (Plasma is a fully ionized gas). Foreign patents have been granted and some are pending. This Arc Plug™ could replace the conventional spark plug in any IC engine as original equipment or as a replacement for spark plugs in existing engines. The Arc Plug is the same size as a traditional spark plug and uses additional electronics. Calculations indicate an improved gas mileage of 40%, increased power and the elimination of the catalytic converter.

From 2002 to 2003, Dr. Ehrlich served as President and Chief Operating Officer of ARTES Medical, Inc., a San Diego based, medical device company with a one-of-a-kind, patented microsphere technology for permanent soft tissue bulking particularly of deep facial wrinkles.

From 1998 to 2002, Dr. Ehrlich was Vice President of SerOptix, Inc., Woburn, MA for which he initiated its fluorescence spectroscopy program, which resulted in a technology for the rapid detection of infectious diseases in transfusion blood such as HIV, Hepatitis C, among others.

From 1982 to 1997, He was a partner in Waverly Capital which provided consulting services to assist in technical and financial growth in diverse areas, primarily in the oil and gas industries, specifically research and development in drilling, logging and hydrocarbon extraction in shale and stripper oil wells.

From 1979 to 1982, Dr. Ehrlich was an Assistant Professor of Physics at City University of New York, Brooklyn College, where he directed research programs in the use of controlled gas phase reactions using relatively low temperature plasmas to synthesize ultra-pure materials and thin films. This technology provides the ability to create refractory thick and thin film materials at ambient temperatures. The applied research was directed to develop improved infra-red sensors for various military applications.

From 1976 to 1979, Dr. Ehrlich served as Research Professor of Physics at Yeshiva University where he directed a staff of faculty and graduate students in a research program in non-invasive cardiology at the Albert Einstein College of Medicine, detecting and measuring low level cardiac electrical activity. Both software and hardware were developed to provide a dynamic electrical map of patients' hearts to detect anomalies. The research effort was to determine whether these small anomalies could be indicative or predictive of heart disease.

From 1961 to 1976, he was President and Chairman of Nuclear Research Associates where he created and directed scientific programs in nuclear weapon phenomenology, primarily of the ELF portion of the electromagnetic spectrum, including effects on the earth's magnetosphere. The expanding plasma of a nuclear device produces significant perturbations of the earth's magnetic field, worldwide. These measurements required the design and construction of special earth current and variometer instruments to measure the time rate of change of the earth's magnetic field before, during and after the detonation of nuclear devices. These devices, developed and built, were installed and operated in a worldwide network for nuclear weapons detection and signal analysis. (U.S. Joint Task Force, Pacific Operations, High Altitude Nuclear device testing, 1962).

Dr. Ehrlich supervised the development of the technology for data reduction of detected signals in a high noise environment. This work included electromagnetic pulse (EMP) and nuclear weapon staging times analysis. In addition, he participated in weapons design to achieve specific tactical results. He developed photochromic materials for both military and commercial applications. These are materials which react to light and, as function of total energy absorbed, change their optical density and are commercially used by the sunglass industry.

From 1955 to 1960, Dr. Ehrlich was a research scientist, Institute of Applied Mathematics at the Courant Institute of New York University (NYU). NYU had the first mainframe digital computer (Univac) in the United States and was the computational facility for the Atomic Energy Commission. Considerable theoretical effort was undertaken in the study of magnetohydrodynamics relating to plasma gas dynamics. In addition to participating in theoretical work, Dr. Ehrlich directed the experimental facility engaged in research in controlled thermonuclear reactions (nuclear fusion). "Project Sherwood" was the code name given to this then secret project.

He is a member of the American Physical Society and New York Academy of Sciences. Dr. Ehrlich has had patents granted in areas as diverse as a thermodynamically pumped laser, scanning microspectrophotometer, photochromics, batteries, and thin film technology. He has published and presented papers on these and other subjects.

Rosendo Alvarez lll, President, stated, "We are pleased to announce that we have appointed Dr. Ehrlich as a Director and Vice-President of Technology. Dr. Ehrlich is a brilliant inventor in the healthcare space as well as the developer of energy-saving devices. He will provide the knowledge and expertise which we need to pursue our planned businesses. We continue to make positive steps to grow the Company."

About: In Ovations Holdings, Inc.

In Ovations Holdings, Inc. is pursuing several potential business opportunities. Its subsidiary, Electro Verde, Inc., is marketing, in conjunction with Coordinated Systems International, the patented GradiLuxtm Total Lighting System Solution which can reduce electricity consumption and carbon emissions in municipal lighting systems worldwide. The Company is also engaged in a Caribbean-based marine-related eco-tourism business and ocean search and recovery operations using state-of-the-art technology. Finally, it is a minority owner of Atmospheric Water Solutions, a company involved in water purification.

Safe Harbor Statement:

Under the Private Securities Litigation Reform Act of 1995: This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Public/Investor Relations: Premier Business Advisors Inc. William A. Young Sr. Phone: 623-238-5245 Email: wayoung55@aol.com